BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5647045)

  • 1. Separation and identification of urinary metabolites of 14C-p-n-butoxyphenylacethydroxamic acid in man.
    Roncucci R; Simon MJ; Lambelin G; Thiriaux J; Buu-Hoi NP
    Biochem Pharmacol; 1968 Feb; 17(2):187-94. PubMed ID: 5647045
    [No Abstract]   [Full Text] [Related]  

  • 2. Biodegradations of the hydroxamic acid group of p-n-butoxyphenylacethydroxamic acid (bufexamac) in various animal species.
    Roncucci R; Simon MJ; Lambelin G; Buu-Hoï NP
    Xenobiotica; 1971; 1(4):567-8. PubMed ID: 5164808
    [No Abstract]   [Full Text] [Related]  

  • 3. Intestinal absorption of p-butoxyphenylacethydroxamic acid and of p-butoxyphenylacetamide. In vitro studies on different segments of rat intestine.
    Roncucci R; Simon MJ; Lambelin G; Gillet C; Thiriaux J; Buu-Hoï NP
    Arch Int Pharmacodyn Ther; 1967 Jun; 167(2):260-4. PubMed ID: 6058775
    [No Abstract]   [Full Text] [Related]  

  • 4. Elimination of 4-n-butoxyphenylacethydroxamic acid (bufexamac) in man.
    Boreham DR; Cummings AJ; Della D; Martin BK
    J Pharm Sci; 1972 Feb; 61(2):164-8. PubMed ID: 4551072
    [No Abstract]   [Full Text] [Related]  

  • 5. [Distribution, metabolism and excretion of a new anti-inflammatory agent: p-butoxyphenyl-acethydroxamic acid (CP 1044 J3)].
    Roncucci R; Simon MJ; Lambelin G; Buu-Hoï NP; Thiriaux J
    Biochem Pharmacol; 1966 Oct; 15(10):1563-75. PubMed ID: 5971809
    [No Abstract]   [Full Text] [Related]  

  • 6. Separation of the urinary metabolites of N-2-fluorenylacetamide on columns of DEAE-cellulose anion exchanger.
    Grantham PH
    Biochem Pharmacol; 1967 Mar; 16(3):429-40. PubMed ID: 6034364
    [No Abstract]   [Full Text] [Related]  

  • 7. Gas-liquid chromatography of hydroxamic acids in biological samples. Detection and quantitation of Bufexamac and one of its major metabolites in plasma and urine.
    Roncucci R; Simon MJ; Lambelin G
    J Chromatogr; 1971 May; 57(3):410-2. PubMed ID: 5091949
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of metabolites of phenylacetic acid in rat brain by plasma desorption mass spectrometry.
    Loo YH; Miller KA; Nowlin J; Horning MG
    Life Sci; 1980 Feb; 26(8):657-63. PubMed ID: 7382743
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of 3,4-dihydroxyphenylacetic acid (DOPAC) in the human.
    Alton H; Goodall M
    Biochem Pharmacol; 1969 Jun; 18(6):1373-9. PubMed ID: 5799111
    [No Abstract]   [Full Text] [Related]  

  • 10. Physiologic disposition of short chain aliphatic hydroxamates in the mouse. II. Absorption, distribution, metabolism and excretion of 1- 14C-acetohydroxamic acid.
    Fishbein WN; Streeter CL; Daly J
    J Pharmacol Exp Ther; 1973 Jul; 186(1):173-82. PubMed ID: 4723309
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic patterns of 4-allyloxy-3-chlorophenylacetic acid in rat, rabbit, dog, monkey, and man.
    Roncucci R; Simon MJ; Lambelin G; Gillet C; Staquet M; Buu-Hoï NP
    Arzneimittelforschung; 1970 May; 20(5):631-6. PubMed ID: 4987566
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of the tissues and gut flora in the metabolism of [14C]homoprotocatechuic acid in the rat and rabbit.
    Dacre JC; Scheline RR; Williams RT
    J Pharm Pharmacol; 1968 Aug; 20(8):619-25. PubMed ID: 4386549
    [No Abstract]   [Full Text] [Related]  

  • 13. The conjugation of 4-chloro- and 4-nitro-phenylacetic acids in man, monkey and rat.
    James MO; Smith RL; Williams RT
    Xenobiotica; 1972 Sep; 2(5):499-506. PubMed ID: 4630830
    [No Abstract]   [Full Text] [Related]  

  • 14. Physiologic disposition of short chain aliphatic hydroxamates in the mouse. I. The one-through-four carbon hydroxamates: excretion and conversion to amides.
    Fishbein WN; Streeter CL
    J Pharmacol Exp Ther; 1970 Aug; 174(2):239-46. PubMed ID: 5451361
    [No Abstract]   [Full Text] [Related]  

  • 15. Separation of heparin into subfractions by DEAE-cellulose chromatography.
    Yue RH; Starr T; Gertler MM
    Thromb Haemost; 1980 Feb; 42(5):1452-9. PubMed ID: 7368152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological study of p-butoxyphenylacethydroxamic acid (CP 1044 J3). II. Toxicological research].
    Lambelin G; Buu-Hoi NP; Mees G; Thiriaux J; Huriaux M
    Med Pharmacol Exp Int J Exp Med; 1966; 15(6):545-54. PubMed ID: 6013064
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycoproteins from bovine duodenal mucosa.
    Cetta G; Pallavicini G; Calatroni A; Castellani AA
    Ital J Biochem; 1972; 21(5):275-88. PubMed ID: 4669561
    [No Abstract]   [Full Text] [Related]  

  • 18. [p-butoxyphenylacethydroxamic acid in the treatment of rheumatic diseases].
    Viara M
    Clin Ter; 1974 Jul; 70(2):153-60. PubMed ID: 4408408
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on urinary phenolic compounds in man. IV. O-Tyrosine and its metabolites.
    Gjessing LR; Borud O
    Scand J Clin Lab Invest; 1966; 18(2):221-6. PubMed ID: 5914748
    [No Abstract]   [Full Text] [Related]  

  • 20. [P-butoxyphenylacethydroxamic acid in analgesic and anti-inflammatory therapy].
    Rosoux E
    Brux Med; 1969 Jul; 49(7):467-9. PubMed ID: 5402954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.